Chimeric crRNA improves CRISPR–Cas12a specificity in the N501Y mutation detection of Alpha, Beta, Gamma, and Mu variants of SARS-CoV-2
Many CRISPR/Cas platforms have been established for the detection of SARS-CoV-2. But the detection platform of the variants of SARS-CoV-2 is scarce because its specificity is very challenging to achieve for those with only one or a few nucleotide(s) differences. Here, we report for the first time that chimeric crRNA could be critical in enhancing the specificity of CRISPR-Cas12a detecting of N501Y, which is shared by Alpha, Beta, Gamma, and Mu variants of SARS-CoV-2 without compromising its sensitivity. This strategy could also be applied to detect other SARS-CoV-2 variants that differ only one or a few nucleotide(s) differences.
Keyword(s):
Keyword(s):
1974 ◽
Vol 32
◽
pp. 514-515
1984 ◽
Vol 42
◽
pp. 196-197
Keyword(s):
1991 ◽
Vol 49
◽
pp. 706-707
1991 ◽
Vol 49
◽
pp. 956-957
◽
1986 ◽
Vol 44
◽
pp. 514-515
1996 ◽
Vol 54
◽
pp. 680-681